The global spinal machined bone allograft market is predicted to exhibit a healthy CAGR during the forecast period 2013 to 2028, according to a report available on Million Insights. Spinal machined bone allografts are defined as implants that are used to repair variety of bone defects in humans. The material which is used to produce these precision grafts is retrieved from donated human tissue.
Growing prevalence of spinal cord disorders or injuries attributed to wrong sitting posture or road accidents is driving demand for effective treatment. Spinal fusion surgery is considered as an effective medical procedure to treat back problems. Increasing spinal fusion surgery volume attributed to favorable reimbursement policies is anticipated to propel market growth. Growing willingness in patients to undergo surgery using minimal invasive techniques is contributing well to market growth. Increasing investment by manufacturing companies in interbody devices will drive the spinal machined bone allograft market over the forecast period.
To cater to rising demand for allograft implants, manufacturing companies are investing in R&D activities to develop effective products. For instance, in February 2019, Medtronic launched demineralized bone matrix (DBM) grafting product called Grafton in Japan. The product is useful is spine and orthopedic surgical procedures. It is an effective bone graft substitute, graft extender, and void filler in the skeletal system. The product form launched in Japan include Grafton Matrix, Grafton putty, Grafton Matrix Strip.
Based on product type, the market can be categorized into gel, putty, and putty with chips. Putty segment is expected to witness highest market share in the coming years owing to improved handling characteristics over gel form.
On the basis of application, the spinal machined bone allograft market can be bifurcated into trauma surgery and spine surgery. Spine surgery segment is anticipated to account for highest market share over the forecast period. This is attributed to growing prevalence of health conditions such as spinal stenosis, degenerative disc disease, osteoarthritis, spinal arachnoiditis, and vertebral fracture. Osteoarthritis of the spine damages cartilage of discs and joints in the neck and lower back. Breakdown of joints creates bone spurs to put pressure on nerves. This can cause pain and weakness in the legs and arms. In severe cases, doctors recommend spinal fusion surgery to provide quick relief from pain. Through surgery, surgeons do fill a gap between two vertebrate using bone graft and screw it using rods or other hardware.
Regional segmentation includes North America, Asia Pacific, Europe, Latin America, and Middle East and Africa. North America is anticipated to hold significant market share attributed to rising cases of spinal cord injuries in the region. Road accidents are the major cause of spinal cord injuries. In addition, growing awareness among people about commercial availability of effective bone allografts is driving the market. Moreover, advanced healthcare infrastructure and rising healthcare expenditure is stimulating regional market growth.
Asia Pacific is expected to witness highest market share over the forecast period owing to improvements in healthcare facilities in the region. Rising cases of spinal cord injuries due to road accidents, violence, and accidental falls are driving demand for bone grafts in the region. In addition, increasing number of geriatric population with spine related disorders is driving demand for spine allografts. The inevitable degeneration of spine among elderly population in China is driving demand for implants in the country. Growing adoption of minimally invasive surgeries among patients to reduce surgery cost will drive regional market growth over the forecast period.
Some of the leading companies operating in the spinal machined bone allograft market are Medtronic, Zimmer Biomet, Xtant Medical, Wright Medical Group, and Hans Biomed. Most companies adopt business strategies such as collaboration or merger and acquisition to expand their product portfolio and to gain competitive edge over others. For instance, in February 2018, Bioventus entered into an agreement with LifeLink Tissue Bank to co-develop a bone allograft for trauma and spine surgery.
Leading players of Spinal Machined Bone Allograft including:
• Zimmer Biomet
• Integra LifeSciences
• RTI Surgical
• Fidia Pharmaceuticals
• Harvest Technologies
• Wright Medical
• Bacterin International
Market split by Type, can be divided into:
Market split by Application, can be divided into:
• Anterior Lumbar Interbody Fusion (ALIF)
• Posterior Lumbar Interbody Fusion (PLIF)
• Transforaminal Lumbar Interbody Fusion (TLIF)
Market split by Sales Channel, can be divided into:
• Direct Channel
• Distribution Channel
Market segment by Region/Country including:
• North America (United States, Canada and Mexico)
• Europe (Germany, UK, France, Italy, Russia and Spain etc.)
• Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
• South America Brazil, Argentina, Colombia and Chile etc.)
• Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)
Research Support Specialist, USA